NSEShareholders meeting18 Jun 2026 · 18 Jun 2026, 05:27 pm

Shareholders meeting

Akums Drugs and Pharmaceuticals Limited · AKUMS

✦ AI SummaryResults

Akums Drugs and Pharmaceuticals Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on July 10, 2026. The meeting will consider and adopt the audited standalone and consolidated financial statements for the financial year ended on March 31, 2026, and the reports of the Board of Directors and Auditors. The meeting will also consider the re-appointment of Mr. Sanjay Sinha as Director, ratify the remuneration of Cost Auditors, and approve the revision in remuneration of Mr. Sanjeev Jain, Managing Director and Promoter.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Akums Drugs and Pharmaceuticals Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on July 10, 2026

Attachments (1)

📄

NSEAKUMS10_18062026172713_AKUMSAGMNOTICE.pdf

pdf

Download →
View document text
Ref: Akums/Exchange/2026-27/23 June 18, 2026 To, To, The Listing Department The Listing Department National Stock Exchange of India Ltd. BSE Limited Exchange Plaza, C-1, Block G, 25th Floor, New Trading Ring, Bandra Kurla Complex, Rotunda Building, Phiroze Jeejeebhoy Bandra (E), Mumbai – 400 051 Towers, Dalal Street, Mumbai – 400 001 Symbol: AKUMS Scrip Code: 544222 Sub: Notice of the 22nd Annual General Meeting Respected Sir/Ma’am, Pursuant to Regulation 30 read with Schedule III of Part A of Para A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Notice of the 22nd Annual General Meeting of Akums Drugs and Pharmaceuticals Limited (“the Company”). The 22nd Annual General Meeting of the Company will be held on Friday, July 10, 2026 at 11:00 A.M. (IST) through Video Conferencing/ Other Audio-Visual Means in accordance with the applicable circulars issued by the Ministry of Corporate Affairs and Securities and Exchange Board of India. The Notice of the 22nd Annual General Meeting is also available on the website of the Company at https://www.akums.in/investors/annual-report/ This is for your information and records. Thanking you, For Akums Drugs and Pharmaceuticals Limited Dharamvir Malik Company Secretary & Compliance Officer Encl.: As above Akums Drugs Pharmaceuticals Limited Notice Manufacturing Excellence. Delivered Globally. 247 NOTICE Notice is hereby given that the Twenty Second (22nd) Annual 3. To re-appoint Mr. Sanjay Sinha (DIN: 03627342) who General Meeting (“AGM”) of the members of Akums Drugs and retires by rotation as Director and being eligible, offers Pharmaceuticals Limited (“the Company” or “Akums”) will be held himself for re-appointment on Friday, July 10, 2026 at 11:00 A.M. (IST) through video To consider and, if thought fit, to pass with or without conferencing/ other audio-visual means to transact the following modification(s), the following resolution as an Ordinary businesses: - Resolution: ORDINARY BUSINESS “RESOLVED THAT pursuant to the provisions of Section 152 1. To receive, consider and adopt and other applicable provisions, if any, of the Companies Act, 2013 and in accordance with Articles of Association of the (a) the audited standalone financial statements of the Company Company, Mr. Sanjay Sinha (DIN: 03627342) who retires by for the financial year ended on March 31, 2026 and the reports rotation at this meeting, and being eligible, offers himself for of the Board of Directors and Auditors thereon; and re-appointment as a Director, be and is hereby re-appointed (b) the audited consolidated financial statements of the as Director of the Company.” Company for the financial year ended on March 31, 2026 and SPECIAL BUSINESS the report of Auditors thereon. 4. To ratify the remuneration of Cost Auditors for the To consider and if thought fit, to pass, with or without financial year 2026-27 modification(s), the following resolutions as Ordinary Resolutions: To consider and if thought fit, to pass with or without modification(s), the following resolution as an Ordinary a) “RESOLVED THAT the audited standalone financial Resolution: statements of the Company for the financial year ended on March 31, 2026 and the reports of the Board of Directors and “RESOLVED THAT pursuant to the provisions of Section 148 Auditors thereon, as circulated to the members, be and are and other applicable provisions, if any, of the Companies Act, hereby considered and adopted. 2013 read with the Companies (Audit and Auditors) Rules, 2014 and the Companies (Cost Records and Audit) Rules, 2014 b) RESOLVED THAT the audited consolidated financial (including any statutory modification(s), or re-enactment(s) statements of the Company for the financial year ended thereof, for the time being in force), on the recommendation on March 31, 2026 and the report of Auditors thereon, as of the Audit Committee and approval by the Board of circulated to the members, be and are hereby considered and Directors, the remuneration of Rs. 3,00,000/- (Rupees Three adopted.” Lakhs Only) plus applicable taxes and reimbursement of out 2. To declare dividend on the equity shares of the of pocket expenses, payable to M/s. Balwinder & Associates Company for the financial year ended on March 31, (Firm Registration No. 000201), Cost Auditors of the Company 2026 to conduct the audit of the cost records of the Company for the Financial Year 2026-27, be and is hereby ratified. To consider and, if thought fit, to pass with or without modification(s), the following resolution as an Ordinary RESOLVED FURTHER THAT the Board of Directors of the Resolution: Company be and is hereby authorized to do all such acts, deeds, matters and things as may be considered necessary, “RESOLVED THAT final dividend of Re. 1/- (Rupee One only) desirable or expedient in order to give effect to this resolution.” and special dividend of Rs. 2/- (Rupees Two only) aggregating to Rs. 3/- (Rupees Three only) (@150%) per equity share of 5. To approve the revision in remuneration of Mr. Sanjeev face value of Rs. 2/- (Rupees Two only) each fully paid-up, as Jain, Managing Director and Promoter of the Company recommended by the Board of Directors, be and is hereby To consider and if thought fit, to pass with or without declared for the financial year ended on March 31, 2026 and modification(s), the following resolution as a Special the same be paid to those members whose names appear Resolution: in the Register of Members or in the Register of Beneficial Owners on Friday, July 03, 2026, out of the profits of the “RESOLVED AS SPECIAL RESOLUTION THAT pursuant Company.” to Sections 196, 197, 198 and other applicable provisions, if ecitoN 62-5202 tropeR launnA detargetnI Notice (Contd.) any, and Schedule V of the Companies Act, 2013 (“the Act”) RESOLVED FURTHER THAT for the purpose of giving effect read with the Companies (Appointment and Remuneration to this resolution, the Board be and is hereby authorized to of Managerial Personnel) Rules, 2014 and Regulation 17(6)(e) do all such acts, deeds, matters and things as it may, in its and other applicable Regulations of SEBI (Listing Obligations absolute discretion, deem necessary, proper or desirable and and Disclosure Requirements) Regulations, 2015 (“Listing to settle any questions, difficulties or doubts that may arise in Regulations”), including any statutory modification(s) or this regard and further to execute all necessary documents, re-enactment(s) thereof for the time being in force and applications, returns and writings as may be necessary, Articles of Association of the Company and in supersession proper, desirable or expedient.” to the Special Resolution passed by the members of the 6. To approve the revision in remuneration of Mr. Sandeep Company in the 20th Annual General Meeting held on Jain, Managing Director and Promoter of the Company May 31, 2024 and on the recommendation of the Nomination and Remuneration Committee and approval of the Audit To consider and if thought fit, to pass with or without Committee and the Board of Directors of the Company, the modification(s), the following resolution as a Special consent of the members of the Company be and is hereby Resolution: accorded for the revision in remuneration of Mr. Sanjeev Jain “RESOLVED AS SPECIAL RESOLUTION THAT pursuant (DIN: 00323433), Managing Director and Promoter of the to Sections 196, 197, 198 and other applicable provisions, if Company with effect from April 01, 2026 for the remainder any, and Schedule V of the Companies Act, 2013 (“the Act”) of his present tenure ending on June 29, 2028, as per the read with the Companies (Appointment and Remuneration terms and conditions detailed in the statement annexed to of Managerial Personnel) Rules, 2014 and Regulation 17(6)(e) the notice. and other applicable Regulations of SEBI (Listing Obligations RESOLVED FURTHER THAT the remuneration includin [Showing first 8,000 characters — download PDF for full document]